Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
tocilizumab | interleukin-6 receptor subunit alpha | biotech | NA | drugbank , DGIDB | Rheumatoid Arthritis Systemic Juvenile[MeSHID:C565798] Rheumatoid Arthritis[MeSHID:D001172] Giant Cell Arteritis[MeSHID:D013700] Juvenile arthritis[MeSHID:D001171] Syndrome[MeSHID:D013577] Patient Discharge[MeSHID:D010351] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] Disease[MeSHID:D004194] |
17.68 | approved | inhibitor,antibody |
tocilizumab | interleukin-6 receptor subunit alpha | biotech | NA | drugbank , DGIDB | Rheumatoid Arthritis Systemic Juvenile[MeSHID:C565798] Rheumatoid Arthritis[MeSHID:D001172] Giant Cell Arteritis[MeSHID:D013700] Juvenile arthritis[MeSHID:D001171] Syndrome[MeSHID:D013577] Patient Discharge[MeSHID:D010351] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
17.68 | approved | inhibitor,antibody |
click here to return to the previous page |